bioRxivCancer Biology
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
L. Zhang, J. I. Hsu, E. D. Braekeleer, C.-w. Chen, T. D. Patel, A. G. Martell, A. G. Guzman, K. Wohlan, S. M. Waldvogel, H. Urya, A. Tovy, E. Callen, R. L. Murdaugh, R. U. Richard, S. Jansen, L. Vissers, B. B. de Vries, A. Nussenzweig, S. Huang, C. Coarfa, J. N. Anastas, K. Takahashi, G. S. Vassiliou, M. A. Goodell
Abstract
The DNA damage response is critical for maintaining genome integrity and is commonly disrupted in the development of cancer. PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D) is a master negative regulator of the response; gain-of-function mutations and amplifications of PPM1D are found across several human cancers making it a relevant pharmacologic target. Here, we used CRISPR/Cas9 screening to identify synthetic-lethal dependencies of PPM1D, uncovering superoxide dismutase-1 (SOD1) as a potential target for PPM1D-mutant cells. We revealed a dysregulated redox landscape characterized by elevated levels of reactive oxygen species and a compromised response to oxidative stress in PPM1D-mutant cells. Altogether, our results demonstrate the protective role of SOD1 against oxidative stress in PPM1D-mutant leukemia cells and highlight a new potential therapeutic strategy against PPM1D-mutant cancers.
- organism: human
- research focus: cancer & tumor microenvironment
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of Small Molecule Inhibitors of PPM1D Using a Novel Drug Discovery Platform
Subrata Shaw, Wei Jiang, … Peter Grant Miller·iSciencePeer-reviewed·Feb 20, 2025
- Distinct Proteasomal Pathways Drive Oncogenic PPM1D Activation
Ni Yan, Deumaya Shrestha, … Peter Grant Miller·bioRxiv·Jun 9, 2026
- DNA damage and oxidizing conditions activate p53 through differential upstream signaling pathways.
T. Shi, P. E. Polderman, … T. B. Dansen·bioRxiv·Sep 13, 2020
- Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma
N. Thongon, F. Ma, … S. Colla·bioRxiv·Feb 22, 2023
- Inhibition of mitochondrial ferredoxin 1 (FDX1) prevents adaptation to proteotoxic stress
P. Tsvetkov, A. Detappe, … S. Lindquist·bioRxiv·Mar 24, 2018
- Succinate Dehydrogenase-Deficient Cancer Cells Have Increased Susceptibility to Ym155 Induced DNA Damage
Qianjin Guo, Sooyeon Lee, … Justin P. Annes·Endocrine Related CancerPeer-reviewed·Feb 19, 2026